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Negative Evidence for a Functional
Role of Neuronal DNMT3a in
Persistent Pain
Jessica Saunders†, Zoe Hore†, Clive Gentry, Stephen McMahon and Franziska Denk*
Wolfson Centre for Age-Related Diseases, King’s College London, London, United Kingdom
Traditionally, neuroscience has had to rely on mixed tissue analysis to examine
transcriptional and epigenetic changes in the context of nervous system function or
pathology. However, particularly when studying chronic pain conditions, this approach
can be flawed, since it neglects to take into account the shifting contribution of different
cell types across experimental conditions. Here, we demonstrate this using the example
of DNA methyltransferases (DNMTs) – a group of epigenetic modifiers consisting of
Dnmt1, Dnmt3a, and Dnmt3b in mammalian cells. We used sensory neuron-specific
knockout mice for Dnmt3a/3b as well as pharmacological blockade of Dnmt1 to study
their role in nociception. In contrast to previous analyses on whole tissue, we find that
Dnmt3a and 3b protein is not expressed in adult DRG neurons, that none of the DNA
methyltransferases are regulated with injury and that interfering with their function has no
effect on nociception. Our results therefore currently do not support a role for neuronal
DNA methyltransferases in pain processing in adult animals.
Keywords: epigenetics, pain, DNMT, DNA methyltransferase, sensory neurons, knockout mice
INTRODUCTION
Persistent pain conditions are common within the general population, affecting about one in five
individuals during the course of their lives (Breivik et al., 2006). Particularly devastating for patients
is chronic pain arising as a result of direct injury or disease of the nervous system, known as
neuropathic pain. It can occur in many disease contexts, for instance diabetes, shingles, or stroke.
Patients can experience a variety of painful symptoms, e.g., spontaneous burning or shooting pain
and evoked pain in response to non-noxious stimuli. Regardless of disease etiology, the disorder
is thought to be characterized by long-lasting hypersensitivity in the nervous system, not only in
peripheral sensory neurons, but also in spinal cord and cortical top-down modulatory circuitry
(Baron et al., 2010).
It is unclear why this hypersensitivity should remain established over such long periods of time.
One way in which cell function can be impacted over long periods of time is through epigenetics
(Denk and McMahon, 2017). Indeed, the role of epigenetic mechanisms is increasingly being
studied in the pain field (Denk et al., 2016; Denk and McMahon, 2017; Niederberger et al., 2017),
as well as in neuroscience in general (Akbarian et al., 2015; Gray et al., 2015; Mo et al., 2015; Halder
et al., 2016; Hannon et al., 2016).
Methylation of cytosines within the DNA sequence is one such epigenetic mechanism. In
mammalian cell types, it most frequently occurs at cytosine–guanine (CG) sites, although in
neurons specifically, up to a fourth of methylated cytosines occur in a non-CG context (Lister et al.,
2013). Methyl groups are added by enzymes known as DNA methyltransferases (DNMTs). There
are three catalytically active DNMTs in mammals, all of them crucial for normal development
and survival: Dnmt1, Dnmt3a, and Dnmt3b. Dnmt1 is thought to primarily copy existing DNA
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methylation patterns upon replication, while Dnmt3a and
Dnmt3b are de novo methyltransferases, capable of modifying
naked CG sites. After development, Dnmt3a continues to be
expressed in post-mitotic neurons in several areas of the brain
(Feng et al., 2005), and studies in knockout mice have suggested
that it plays a role in a variety of neuronal functions, such as
motor coordination (Nguyen et al., 2007), olfaction (Colquitt
et al., 2014) and synaptic plasticity in the context of memory
(Feng et al., 2010; Morris et al., 2014) and reward (LaPlant et al.,
2010). Thus, it seemed reasonable to hypothesize that DNMTs
might also be relevant for processing of sensory stimuli. Indeed,
last year, two back-to-back publications from the same group
suggested a role for Dnmt3a in nociceptive neuron function and
pain processing after nerve injury (Sun et al., 2017; Zhao et al.,
2017).
However, here we present evidence that runs counter to these
findings. In contrast to previous work, we use cell-type specific
data, pharmacological tools and a sensory neuron-specific
Dnmt3a/3b knockout mouse to demonstrate that DNMTs are
unlikely to play a role in sensory neurons in adult animals. Most
strikingly, our data indicate that Dnmt3a and 3b proteins are not
expressed in adult DRG neurons and are not upregulated with
injury. In line with this, their knockout had no measurable effect
on nociception.
MATERIALS AND METHODS
Animals
For the experiment in Figure 6, C57BL/6J male mice were
purchased from Harlan at 8 weeks of age and acclimatized for
1 week before behavioral testing.
For all other experiments, age-matched cohorts of mice
were bred from Dnmt3a/Dnmt3b double floxed mice
(Dnmt3afl/fl/Dnmt3bfl/fl) (Dodge et al., 2005) crossed with
an inducible sensory neuron-specific Cre line (AdvCreERT2) (Lau
et al., 2011). AdvCreERT2 positive and negative littermates were
generated through breeding from one hemizygous BAC+ and
one BAC negative parent. The resulting line was maintained on
a 129Sv hybrid background, and consequently showed higher
baseline sensitivity to nociceptive stimuli than C57BL/6J mice, as
described by Mogil et al. (1999a,b).
Mice were housed in standard open-topped cages in groups of
five maximum at 12 h light–dark cycle. All experiments described
were carried out in accordance with the United Kingdom Home
Office Legislation (Scientific Procedures Act, 1986) and were
approved by the Home Office to be carried out at King’s College
London under project license 70/8015.
Drugs
Tamoxifen (T5648, Sigma) was used to induce deletion of
Dnmt3a and Dnmt3b in sensory and sympathetic neurons in a
time-dependent manner. 1 g of tamoxifen was weighed out and
vortexed in 2 ml 100% EtOH before being dissolved in 23 ml sun
flower or wheat germ oil through vigorous shaking for 30 min
(final concentration: 7.8 mg/ml). The compound was delivered
to mice three times in 1 week, each time injected i.p. at 75 mg/kg.
RG108 was obtained from Abcam (ab141013) and delivered at
15 µg intrathecally in 9% DMSO. Vehicle controls were injected
with 9% DMSO only. For the CFA experiment, RG108 was
injected 30 min before and 47 h after CFA administration. In the
partial sciatic nerve ligation model, RG108 was injected on three
consecutive days, starting 30 min before surgery. An additional
“booster” dose was delivered 8 days after surgery.
Complete Freund’s Adjuvant Model (CFA)
After obtaining baseline von Frey thresholds, C57BL/6J mice
were pseudo-randomized into groups and treated with RG108
or vehicle (n = 8) 30 min before an intraplantar CFA injection
(F5881, Sigma, 20 µl per paw). A second RG108 injection was
given 47 h after CFA. Behavior was assessed with von Frey hairs
using the Dixon up–down method (Chaplan et al., 1994) at 5, 22,
48, and 72 h after CFA by an experimenter blind to treatment
group. Each time, the mice were allocated to different von Frey
boxes at random. Three hours after the last behavioral time point,
the animals were overdosed with pentobarbital and perfused with
PBS. Lumbar DRG (L3-L5) were removed, snap frozen in liquid
nitrogen and stored at−80◦C for subsequent ELISA.
Partial Sciatic Nerve Ligation Model
A cohort of male AdvCreERT2-Dnmt3afl/fl/Dnmt3bfl/fl and
their age-matched littermate controls (Dnmt3afl/fl/Dnmt3bfl/fl,
n = 9) were treated with tamoxifen as described above
and, 18 days later, subjected to partial sciatic nerve ligation
under isofluorane anesthesia. Briefly, after administration of an
analgesic (0.05 mg/kg buprenorphine), the sciatic nerve was
exposed through blunt dissection and tightly ligated with a 5.0
suture. The wound was stapled shut, and the mice left to recover.
In addition to the genetic manipulation of Dnmt3a and
Dnmt3b, mice were also intermittently treated with intrathecal
RG108 to insure against any compensatory effects of Dnmt1 (see
above and Supplementary Table 1 for details).
Mechanical and thermal sensitivity was assessed using von
Frey and hot plate tests at baseline before, as well as at varying
intervals after surgery (see Supplementary Tables 2, 3 for
details). All testing was carried out by an experimenter blind to
genotype and RG108 treatment group, and on different testing
days, mice were allocated to different von Frey boxes at random.
Protein Extraction and Western Blotting
DRG, spinal cord and brain were extracted from AdvCreERT2-
Dnmt3afl/fl/Dnmt3bfl/fl transgenic mice and their littermate
controls (n = 3) either with or without prior PBS perfusion.
Depending on the experiment, extractions were performed
1–4 weeks after tamoxifen injections.
For protein extraction, the tissue was shaken for 2 h at room
temperature in 0.2% SDS and protease inhibitors in ultrapure
water. The remaining extracellular matrix was spun down and
the supernatant removed for Nanodrop quantification before
Western blotting.
Western blots were carried out according to standard
protocols, with samples being run on 4–12% Bis-Tris gels
and being transferred onto PVDF membranes. The following
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antibodies were used: Dnmt3a (mouse, 1:250, Enzo, ALX-
804-370-C100) and Gapdh (rabbit, 1:10000, Sigma, G9545) or
α-tubulin (mouse, 1:1000, Sigma, T9026) as loading controls.
5-mC ELISA
DNA was extracted from L3-L5 DRG using a Qiagen DNeasy
Blood & Tissue Kit (69504) following manufacturer’s protocols.
Once purified, the DNA was diluted to 8 ng/µl in 5-mC buffer
delivered with the 5-mC DNA ELISA Kit (Zymo Research,
D5325). Kit instructions were then followed. Briefly, 100 ng of
DNA and methylation standards (0–100% methylated 5-mC)
were used to coat a PCR plate. The samples were washed, before
blocking in 200 µl 5-mC ELISA buffer for 30 min and incubation
with primary (5-mC) and secondary antibodies for 1 h. After
further washes, the HRP signal was developed for 30 min at room
temperature and read at 420 nM on a plate reader.
RNA Extraction and qRT-PCR
After the completion of behavioral experiments, RNA was
extracted from L3-L5 DRG of knockout mice and their littermate
controls using a Qiagen RNeasy Microkit (74004) according
to the manufacturer’s protocol. qRT-PCR was carried out with
Taqman probes against Dnmt3a (Dnmt3a-Mm00432881_m1),
Dnmt3b (Dnmt3b-Mm01240113_m1) and Dnmt1 (Dnmt1-
Mm01151063_m1). The geometric mean of housekeeping
genes Ywhaz (Ywhaz-Mm01158416_g1), Gapdh (Gapdh-
Mm99999915_g1), and 18S (18S-Hs99999901_s1) was used to
calculate the 2−1CT values plotted in Figure 1.
Immunofluorescence
Adult or P2 AdvCreERT2-Dnmt3afl/fl/Dnmt3bfl/fl and their Cre-
negative littermates were dosed with tamoxifen (3 × 75 mg/kg
i.p. in adults as described above or 1x 75 mg/kg i.p. in P2 pups).
A week (in the case of adults) or 14 days later (at P16), mice
were culled by transcardial perfusion with 0.1 M PB and 4%
paraformaldehyde. DRG were cryoprotected in 25% sucrose and
cut into 10 micron sections on a cryostat. For immunofluorescent
staining, sections were incubated for 2 h in blocking serum
(10% donkey serum; 0.2% Triton; 0.1% sodium azide in PBS)
and stained with antibodies against Dnmt3a (rabbit anti-mouse,
1:1000, Abcam, ab2850 or mouse anti-mouse, 1:500, Santa
Cruz, sc-373905), NF200 (chicken anti-mouse, 1:500, Millipore,
AB5539) and Iba1 (rabbit anti-mouse, 1:500, Wako, 019-19741)
overnight. After three washes in PBS, sections were incubated
with secondary antibodies for 2 h at room temperature: Alexa
Fluor488 (donkey anti-rabbit or donkey anti-mouse, 1:1000,
Invitrogen, A-21206 or A-21202), Alexa Fluor546 (goat anti-
chicken, 1:1000, Invitrogen, A-11040), and Alexa Fluor647 (goat
anti-rabbit, 1:1000, A-21244). After further washes in PBS,
sections were mounted using Fluoromount-G mounting medium
with DAPI (Invitrogen) and imaged on a Zeiss LSM 710 confocal
microscope.
Statistical Methods
Behavioral results were evaluated using two-way repeated
measures ANOVAs with paw (ipsi vs. contralateral) and
time (after CFA or nerve injury) as within-subject variables
and treatment or genotype as between-subject variables. For
molecular results, we performed independent samples t-tests.
RESULTS
On an RNA level, we were able to demonstrate
that administration of tamoxifen to AdvCreERT2-
Dnmt3afl/fl/Dnmt3bfl/fl mice resulted in knockdown of Dnmt3a,
with no compensatory upregulation of Dnmt1, as measured
by qRT-PCR performed on whole DRG (Figure 1). Western
blots conducted at the time on unperfused mouse DRG also
suggested that Dnmt3a was detectable and could be knocked
down genetically in AdvCreERT2 positive floxed mice (data not
shown).
FIGURE 1 | Dnmt3a knockdown after tamoxifen administration to AdvCreERT2-Dnmt3afl/fl/Dnmt3bfl/fl mice. DNMT expression measured by qRT-PCR in whole
L3-L5 DRG taken from sensory neuron specific Dnmt3a and Dnmt3b knockout mice. While Dnmt3b was absent, Dnmt3a knockout was significant in both male (A,
two-tailed independent samples t-test, p = 0.01, n = 3) and female mice (B, two-tailed independent samples t-test, p = 0.03, n = 3 and 4). There appeared to be no
compensatory shift in Dnmt1 expression as a result of the genetic manipulation. Values are expressed as 2−1CT with respect to three housekeeping genes. Each
data point (circles for Dnmt1, squares for Dnmt3a and diamonds for Dnmt3b) represents one biological replicate. Means and their standard errors are also displayed.
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FIGURE 2 | Dnmt3a/3b knockout, even in conjunction with pharmacological Dnmt1 blockade, had no significant effect on mechanical hypersensitivity induced by
nerve injury in mice. AdvCreERT2-Dnmt3afl/fl/Dnmt3bfl/fl and their age-matched littermate controls (Dnmt3afl/fl/Dnmt3bfl/fl, n = 9) were treated with tamoxifen and
their mechanical hypersensitivity was assessed using von Frey filaments before (BL-1, BL-2) and after partial sciatic nerve ligation surgery (day 2, day 5, day 8, day
10, day 14). The Dnmt1 inhibitor RG108 was delivered intrathecally 30 min before surgery (day 0), as well as at varying intervals after surgery (day 1, day 2 and day
8, indicated by the black arrows). Plotted are 50% withdrawal thresholds in grams for the ipsilateral paw of each individual animal (diamonds for knockout mice,
circles for their littermate controls), as well as their means and standard errors (red and gray bars for knockouts and littermates, respectively). The dotted line
indicates the mean baseline withdrawal threshold. See Supplementary Table 1 for raw data and further details.
However, there did not appear to be any functional
consequences of sensory-neuron specific Dnmt3a/3b knockout.
Mechanical sensitivity thresholds in mice were unaffected by
genotype, either at baseline or after partial sciatic nerve ligation
(Figure 2, Supplementary Figure 1 and Table 1). A repeated-
measures ANOVA with genotype as the dependent variable and
time and paw as independent variables revealed a significant main
effect of time (pre- and post-surgery, p = 0.003), a significant
main effect of paw (ipsi- vs. contralateral, p = 0.001) and a
significant interaction between time× paw, in that the ipsilateral
paw showed lowered sensitivity thresholds only after surgery
(p = 0.02). However, no significant main or interaction effects
involving genotype could be observed. These outcomes were
not altered by additional pharmacological inhibition of Dnmt1
using intrathecal administration of the small molecule inhibitor
RG108 (black arrows). This suggests that the only remaining
DNMT in these mice was not responsible for functionally
rescuing and therefore camouflaging an effect of Dnmt3a/3b
deletion.
The same was true when we measured thermal sensitivity
using a hot plate (Supplementary Figure 2 and Table 2): a
repeated-measures ANOVA showed a significant main effect of
time (baseline vs. day 9 after surgery, p = 0.042), but no other
significant changes.
To make sense of this finding, we went back to examine
DNMT expression levels in mouse DRG in a cell-type
specific fashion. On an RNA level, sequencing experiments
on purified DRG neurons (Thakur et al., 2014; Motti et al.,
2017) suggest that Dnmt1 is the most clearly expressed
methyltransferase, while Dnmt3b is absent and Dnmt3a is at
or just above the limit of detection thresholds (Supplementary
Figure 3A). In contrast, unperfused intact whole DRG showed
higher levels of Dnmt3a, suggesting that the methyltransferase
may be present in non-neuronal tissues or blood. Besides
naïve expression levels, we also examined neuronal DNMT
levels after nerve injury and found Dnmt1, 3a and 3b
mRNA expression to be unchanged (after sciatic nerve crush,
Supplementary Figure 3B and after partial sciatic nerve ligation,
Supplementary Figures 3C,D). Finally, immunohistochemistry
experiments with two different antibodies indicated that
Dnmt3a protein is expressed in DRG neurons during postnatal
development (P16) in wild-type but not knockout tissue, yet
ultimately downregulated below detection levels in adult mice
(Figure 3).
We therefore think it likely that Dnmt3a protein content
in unperfused whole DRG derives from non-neuronal cells.
Expression data derived from BLUEPRINT suggest that
peripheral blood mononuclear cells (PBMCs) and leukocytes
could be possible candidates (Supplementary Figure 4). We
conducted a few small scale experiments to test these options.
PBS perfusion of our tissue did not alter the level of Dnmt3a in
Western blots significantly (Figure 4A), suggesting that PBMCs
are not a likely source of this protein in mouse DRG. Instead,
we found that mouse bone-marrow derived macrophages test
positively for Dnmt3a in Western blots, making it possible that
myeloid cell types express Dnmt3a in adulthood (Figure 4B).
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FIGURE 3 | Immunostaining against Dnmt3a indicates lack of neuronal protein
expression in the adult. Representative confocal images of DRG cryosections
from P16 and adult AdvCreERT2 Dnmt3a KO mice and their littermate controls.
Sections were stained with NF200 (red), DAPI (blue) and an antibody against
Dnmt3a (green) from Santa Cruz (A–D) or Abcam (A∗–D∗). Scale bar: 50 µm.
However, when we went on to test non-neuronal Dnmt3a
expression with immunofluorescent staining of DRG, a more
complex picture emerged: of the two Dnmt3a antibodies we
knock-out validated, only the Santa Cruz version produced any
signal in adult non-neuronal cell types in our sections (compare
Figures 3A,C to A∗,C∗ and see Figure 5A). But this non-
neuronal staining did not appear to overlap with Iba1, a marker
for myeloid cell types (Figures 5B,C). In conclusion then, much
more detailed work is needed to ascertain whether Dnmt3a is
really present in non-neuronal cells in the adult and, if so, which
ones. It is for instance possible that DRG macrophages start
expressing Dnmt3a when they adopt certain phenotypes in injury
states. Equally, it is possible that the signal observed with the
Santa Cruz antibody derives from dividing fibroblasts or satellite
glia.
Finally, given that Dnmt1 appears to be the only DNMT
that is expressed in adult neurons to significant levels, we
chose to explore its role in nociception in a little more
detail. Having observed no behavioral effects of the Dnmt1
inhibitor RG108 in a model of partial sciatic nerve ligation, we
chose to further examine Dnmt1 in a model of inflammatory
hypersensitivity. RG108 was delivered intrathecally to C57BL/6J
wild-type mice 30 min before and 47 h after intraplantar injection
of CFA. As was the case after nerve injury, no significant
changes in mechanical sensitivity thresholds between groups
were measurable (Figure 6A and Supplementary Table 3),
despite a 43% reduction in global 5-mC DNA methylation
levels being observed in the dorsal root ganglia of treated mice
compared to their vehicle counterparts (Figure 6B).
DISCUSSION
Our results, together with findings from publicly available
sequencing data, make us confident that Dnmt3a and Dnmt3b
proteins are not expressed at easily detectable level in
adult mouse DRG neurons. At mRNA level, Dnmt3b is
also completely absent, while low quantities of Dnmt3a can
be measured and further reduced via genetic knockout in
AdvCreERT2-Dnmt3afl/fl/Dnmt3bfl/fl mice. It is unclear whether
this Dnmt3a message has any functional role, given that it is
not translated into appreciable amounts of protein in adult
wild-type animals. During development, Dnmt3a protein is
present at least until P16, and indeed, single cell data suggest
it could be found in neurons, particularly non-peptidergic
ones, beyond that time: at P20-P23, Dnmt3a mRNA appears
to exceed Dnmt1 mRNA levels in single cells (Zeisel et al.,
2018).
Upon nerve injury, neuronal mRNA expression of any of
the three DNMTs does not appear to be significantly altered in
nociceptors. It consequently comes as no surprise that interfering
with Dnmt3a and 3b function in sensory neurons has no impact
on sensory perception, neither at baseline nor after partial sciatic
nerve ligation.
It is not unusual for mRNA to be present in the absence
of protein. On a genome-wide level, mRNA abundance has
classically been reported to be only moderately predictive of
protein levels, with correlations ranging from 30 to 50% (Csardi
et al., 2015; Edfors et al., 2016). At steady state, the extent of this
disconnect may appear exaggerated due to technical factors, such
as failure to correctly take into account missing values, noise and
the non-linear relationship between mRNA and proteins (Li et al.,
2014; Csardi et al., 2015). Indeed, when re-evaluated with these
features in mind, estimated correlations between mRNA and
protein content range from a minimum of 56% to a maximum of
85%. Nevertheless, especially in the case of lowly expressed genes
like Dnmt3a, it is likely common for mRNA to be degraded or
translated at very low rates.
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FIGURE 4 | Dnmt3a signal in Western blots does not vary with blood content and is strongest in mouse bone-marrow derived macrophages. (A) Dnmt3a signal did
not vary with blood content or genotype. Adult DRG were taken from PBS perfused and non-perfused AdvCreERT2 mice (+) and their Cre-negative littermate controls
(–). The signal is quantified relative to the housekeeper (α-tubulin). Each data point (diamonds for perfused, circles for non-perfused tissue) represents one biological
replicate. Means and their standard errors are also displayed. (B) Bone marrow derived macrophages (BMDMs) were cultured from a C57BL/6J mouse for
comparison. Samples of spinal cord are also displayed. GAPDH expression used as a protein loading control. Break indicates splicing of blot to remove additional
DRG and brain samples.
FIGURE 5 | Non-neuronal Dnmt3a signal in adult mouse DRG does not
overlap with Iba1 staining. Confocal images of adult mouse DRG cryosections
after staining with Dnmt3a (green) and Iba1 (purple) indicate that non-neuronal
Dnmt3a signal does not co-localize with Iba1 (A,B). (C) Co-staining of NF200
(cyan) and Iba1 (purple). Blue channel: DAPI.
Our findings on DNMT mRNA expression are in keeping with
publicly available RNA-seq data on whole human DRG (Flegel
et al., 2015; Ray et al., 2018), which report normalized expression
values that are similar to those we report here in mouse neurons:
clear expression of Dnmt1, borderline expression of Dnmt3a
and absence of Dnmt3b message. In contrast, these mRNA data
and our other findings run counter to two previously published
manuscripts from the same group which present evidence for the
involvement of Dnmt3a in nociception in rats and mice (Sun
et al., 2017; Zhao et al., 2017). At present, we cannot explain
this discrepancy. We used the Santa Cruz antibody reported by
Tao and his colleagues, as well as another Abcam antibody, but
with neither could replicate the staining patterns observed by the
authors in their two papers.
Besides Dnmt3a/3b, our experiments suggest that Dnmt1 may
also not be relevant in the context nociception, although the
conclusions we can draw are less firm. In neuropathic pain, we
temporally inhibited Dnmt1 function using intrathecal delivery
of the small molecule inhibitor RG108 30 min before sciatic nerve
ligation surgery. We also measured behavioral effects 2 and 8 days
after injury, each time within hours of a further injection. At the
time we conducted our behavioral experiments, the half-life of
Frontiers in Molecular Neuroscience | www.frontiersin.org 6 September 2018 | Volume 11 | Article 332
fnmol-11-00332 September 10, 2018 Time: 17:35 # 7
Saunders et al. Neuronal Dnmt3a in Persistent Pain
FIGURE 6 | Dnmt1 inhibition has no effect on hypersensitivity induced by inflammation in mice. (A) Intrathecal administration of the Dnmt1 inhibitor RG108 30 min
before and 47 h after intraplantar CFA administration (black arrows) had no effect on mechanical sensitivity as measured by von Frey. Plotted are 50% withdrawal
thresholds in grams for each individual animal (diamonds for RG108 treated mice, circles for their vehicle-treated controls), as well as their means and standard
errors (red and gray lines for knockouts and littermates, respectively). See Supplementary Table 3 for raw data and further details. (B) ELISA against global 5-mC
levels demonstrated a 43% reduction in DRG methylation in RG108- versus vehicle-treated mice. This effect was near-significant at p = 0.055 (one-tailed
independent samples t-test, with unequal variances assumed).
RG108 had only been measured in vitro, where it was reported
to be approximately 20 days (Brueckner et al., 2005). Today,
an in vivo study suggests that RG108 delivered subcutaneously
may only be active for about 4 h (Schneeberger et al., 2016).
In our experimental context, its effects were measurable for
slightly longer than that, with reduced 5-mC levels still being
observed approximately 24 h after the last intrathecal injection
(Figure 6B). Nevertheless, we have to assume that the drug
would not have remained in the system of our mice for much
longer than that. And while we observed a drop in global DNA
methylation, it is still conceivable that the function of Dnmt1
was not sufficiently inhibited to unmask a phenotype. It has been
suggested (Feng et al., 2010) that Dnmt1 has the capacity to act
as a de novo methyltransferase in neurons, in addition to its
main role in maintaining existing DNA methylation patterns. In
principle therefore, the enzyme could impact how sensory neuron
DNA is methylated in adult animals. Further experiments will
be required to resolve the role of Dnmt1 in nociception more
unambiguously.
We think that a couple of lessons can be garnered from
this evidence that go beyond DNMT function and nociception.
Firstly, we proceeded to our behavioral experiments based
on qRT-PCR and a Western blot result that appeared to
demonstrate knockdown in n = 3 animals. However, as can
be easily observed from the Western blot ultimately published
in this paper: larger scale and more thorough investigations
revealed that the protein signal did not actually vary consistently
between knockout and wild-type animals (Figure 4A). This
result is in keeping with our immunohistochemistry data
suggesting that Dnmt3a is not expressed in adult sensory
neurons and consequently unaffected by Advillin-Cre driven
knockout. Moreover, it can serve as an important reminder
that small n numbers (< 5) are likely to yield many false
positive results (Curtis et al., 2018), especially in the context
of mixed tissue where variability between samples can be
exacerbated by differences in tissue composition, such as a few
extra drops of blood or a few millimeters of additional dorsal
root.
Secondly, particularly when studying epigenetics and
epigenetic modifiers such as DNMTs, it is vital to conduct
studies in a cell-type specific manner. While there are
instances in which epigenetic marks across different tissues
are correlated (Bakulski et al., 2016), evidence accumulating
over the last decade has made it plain that – as a rule –
both DNA methylation and histone modifications are
highly dependent on cell-type (Martens and Stunnenberg,
2013; Schultz et al., 2015; Halder et al., 2016). This is an
unsurprising fact when one considers that it is a cell’s epigenetic
profile which determines which genes are accessible and
therefore what phenotype the cell adopts once development
is complete (Cantone and Fisher, 2013; Heinz et al.,
2015).
In the context of pain, this need for cell-type specificity
is particularly acute. Most of the models commonly used in
the field, be they models of nerve injury (e.g., sciatic nerve
ligation, chronic constriction injury, spared nerve injury) or
inflammation (e.g., injections of carrageenan or CFA), majorly
disrupt cell composition in many areas. For instance, peripheral
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immune cells infiltrate into nerve or skin, and central
nervous system immune cells proliferate in neuropathic models.
Consequently, “painful” and “non-painful” experimental groups
examined on a global, tissue-unspecific level, will differ vastly
in terms of their epigenetic profile, mRNA level and protein
content. An apparent pain-related epigenetic change in gene
X can therefore sometimes simply reflect the native epigenetic
state of an infiltrating immune cell. And consequently, failure to
eliminate tissue composition as a confounding factor may lead
to a confused picture of the role of epigenetics in chronic pain
(Laumet et al., 2015; Sun et al., 2017; Zhao et al., 2017).
CONCLUSION
Our study does not currently support a role for DNMTs in
sensory neuron processing. In particular, Dnmt3a and Dnmt3b
do not appear to be expressed in adult primary sensory neurons at
protein level and consequently their knockout in this cell type has
no effect on nociception either in naïve animals or in the context
of nerve injury.
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FIGURE S1 | Dnmt3a/3b knockout had no significant effect on mechanical
sensitivity in the paw contralateral to nerve injury. AdvCreERT2-Dnmt3afl/fl/
Dnmt3bfl/fl and their age-matched littermate controls (Dnmt3afl/fl/Dnmt3bfl/fl,
n = 9) were treated with tamoxifen and their mechanical hypersensitivity was
assessed using von Frey filaments before (BL-1, BL-2) and after partial sciatic
nerve ligation surgery (day 2, day 5, day 8, day 10, day 14). The Dnmt1 inhibitor
RG108 was delivered intrathecally 30 min before surgery (day 0), as well as at
varying intervals after surgery (day 1, day 2 and day 8, indicated by the black
arrows). Plotted are 50% withdrawal thresholds in grams for the contralateral paw
of each individual animal (diamonds for knockout mice, circles for their littermate
controls), as well as their means and standard errors (red and gray bars for
knockouts and littermates, respectively). The dotted line indicates the mean
baseline withdrawal threshold. See Supplementary Table 1 for raw data and
further details.
FIGURE S2 | Dnmt3a/3b knockout had no effect on thermal sensitivity.
AdvCreERT2-Dnmt3afl/fl/Dnmt3bfl/fl and their age-matched littermate controls
(Dnmt3afl/fl/Dnmt3bfl/fl, n = 9) were treated with tamoxifen and their thermal
hypersensitivity was assessed using a hotplate test before (BL) and nine days after
partial sciatic nerve ligation surgery (day 9). Plotted is the temperature (in ◦C) at
which individual mice displayed pain (flicking or licking of the paw) or escape
behavior (jumping): diamonds for knockout mice, circles for their littermate
controls. Means and standard errors are also displayed (red and gray lines for
knockout and littermate controls, respectively). See Supplementary Table 2 for
raw data and further details.
FIGURE S3 | RNA expression level of DNMTs in purified DRG neurons. (A) DNMT
expression levels in whole DRG, dissociated DRG and magnetically sorted
nociceptors, derived from publicly available data (Thakur et al., 2014). The dotted
line indicates the expression threshold suggested by the authors as appropriate
for their dataset. (B) DNMT expression levels in sorted sensory neurons after
sciatic nerve crush, derived from publicly available data (Motti et al., 2017). (C,D)
DNMT expression levels in magnetically sorted nociceptors after partial sciatic
nerve ligation in (C) male and (D) female mice. Expression values are displayed as
a fraction of a housekeeping gene. Circles indicate individual biological replicates.
Their means and standard errors are also plotted.
FIGURE S4 | mRNA expression levels of Dnmt3a in various blood-derived cell
populations as derived from BLUEPRINT. Dnmt3a message is present in human
neutrophils, macrophages, inflammatory macrophages, alternatively activated
macrophages, monocytes, dendritic cells, various different kinds of T cells, naïve B
cells and peripheral blood-derived mononuclear cells (PBMCs). Data are
expressed in FPKM and derived from the BLUEPRINT (Martens and Stunnenberg,
2013) website (data release 2016-08).
TABLE S1 | No effect of Dnmt3a/3b knockout on nerve injury: von Frey data.
TABLE S2 | No effect of Dnmt3a/3b knockout on nerve injury: hot plate data.
TABLE S3 | No effect of Dnmt1 inhibition on inflammatory pain: von Frey data.
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